Evoq Remedies gets ROC nod to extend FY26 AGM deadline to Oct 30
- Evoq Remedies Limited received ROC approval to extend its 16th AGM deadline
- New due date for the FY26 AGM is October 30, 2026
- Extension granted due to ongoing Corporate Insolvency Resolution Process
- Application was filed by the Resolution Professional on September 28, 2026
*this image is generated using AI for illustrative purposes only.
Evoq Remedies Limited has secured approval from the Registrar of Companies (ROC) Ahmedabad to extend the deadline for holding its 16th Annual General Meeting (AGM) for FY26. The new due date is October 30, 2026, following a request linked to the company's ongoing Corporate Insolvency Resolution Process (CIRP).
The company, currently undergoing CIRP under the Insolvency and Bankruptcy Code, 2016, applied for the extension on September 28, 2026. The ROC granted a one-month extension under Section 96(1) of the Companies Act, 2013, moving the original September 30, 2026 deadline.
Regulatory Approval Details
The ROC order, dated September 30, 2026, cited the company's inability to hold the AGM on time due to the insolvency proceedings. The Resolution Professional, Dipti Narayan Mundra, filed the application on behalf of the company. The ROC advised the company to ensure future compliance with statutory timelines.
| Item | Detail |
|---|---|
| Original AGM Due Date | September 30, 2026 |
| Extended AGM Due Date | October 30, 2026 |
| Extension Granted | 1 month |
| Reason | Ongoing CIRP proceedings |
Next Steps
The company will announce the date, time, and venue of the AGM separately in accordance with SEBI (LODR) Regulations and the Companies Act, 2013. The approval letter from the ROC has been attached as an annexure to the disclosure.
Historical Stock Returns for Evoq Remedies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.65% | +5.56% | 0.0% | -33.91% | -61.52% | -93.60% |
How might the ongoing Corporate Insolvency Resolution Process impact the specific agenda items and shareholder resolutions at the upcoming 16th AGM?
What are the potential market reactions or credit rating implications for Evoq Remedies Limited given the extended timeline for statutory compliance?
Will the Resolution Professional propose any restructuring plans or asset sale updates during the October AGM that could influence creditor recovery rates?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
